-
September 14, 2021
-
September 14, 2021
EISAI TO PRESENT ABSTRACTS ON ONCOLOGY PRODUCTS AND PIPELINE AT ESMO VIRTUAL CONGRESS 2021
-
September 13, 2021
-
August 31, 2021
-
August 16, 2021
-
August 30, 2021
-
August 5, 2021
-
August 4, 2021
IR “First Quarter Financial Report for the Fiscal Year Ending March 31, 2022”
-
July 30, 2021
-
July 20, 2021
-
April 19, 2021
Eisai formulates the action plan “Diversity & Inclusion 2021”
-
December 10, 2020
Notice of Emergence of Employees Infected with the Novel Coronavirus at the Bogor Plant in Indonesia
-
December 3, 2020
EISAI ITALY AWARDED HIGHEST CLASSIFICATION AT FIFTH ANNUAL WELFARE INDEX PMI* IN ITALY
-
October 28, 2020
-
August 4, 2020
Notice of Emergence of Employees Infected with the Novel Coronavirus at Eisai’s Vizag Plant in India
-
Annual Financial Results for the Fiscal Year Ended March 31, 2021
-
Our Response to the Novel Coronavirus Infection
-
Florence Nightingale Virtual Gallery
-
#ThisIsMBC Elements Campaign Showcases Powerful Portraits of Patients Living with Metastatic Breast Cancer and Their Caregivers Sharing Their Journeys to Inspire Others
Eisai's hhc Philosophy
Sustainability
28 countries 2.02 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of August 2021)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
